Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04647370
Other study ID # Ischemic Preconditioning
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date April 1, 2021
Est. completion date March 2022

Study information

Verified date April 2021
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aim of the work : Evaluation of the role of Remote Ischemic Preconditioning (RIP) on liver function in patients undergoing on-pump cardiac surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date March 2022
Est. primary completion date January 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: 1. Being candidate for on-pump cardiac surgery. 2. Willing to participate in the study 3. Ages eligible for the study: 18 to 70 years. 4. Gender eligible for the study : both Exclusion Criteria: 1. Patient refusal. 2. Known cause of possible liver function disturbances that includes right heart failure, acute inflammation of gallbladder or any other complication of gallstone disease. 3. Active viral and non viral hepatitis. 4. Pregnant women. 5. History of peripheral nerve disease or peripheral vascular disease of the extremities

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
remote ischemic preconditioning
3 cycles of 5-minutes inflation of a blood pressure cuff to 200mmHg (or at least to a pressure 50mm Hg higher than the systolic arterial pressure) to one upper arm, followed by5-minutes reperfusion with the cuff deflated
Sham remote ischemic preconditioning
3cycles of upper limb pseudo ischemia (low pressure, 5-minutes blood pressure cuff inflation to a pressure of 20 mm Hg and 5-minutes cuff deflation).

Locations

Country Name City State
Egypt Assiut University hospital Assiut Asyut Governorate

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary liver function test Direct Bilirubin 3 postoperative days
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06369350 - Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion Early Phase 1
Withdrawn NCT04388761 - Feasibility and Safety of Allogeneic Adipose Mesenchymal Stem Cells (aMSCs) Delivery Into Kidney Allografts Procured From Deceased Donors With High Kidney Donor Profile Index (KDPI) Phase 1
Completed NCT00987974 - Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury Phase 4
Recruiting NCT04750616 - NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial Phase 2
Recruiting NCT05992259 - Auricular Vagus Stimulation and STEMI N/A
Completed NCT04493983 - Role of Oxidative Stress in Ovarian Tissue After CO2-pneumoperitoneum Application-induced I/R N/A
Completed NCT03510793 - Microcirculation and Anesthesia in Vascular Surgery
Recruiting NCT02845154 - Intermittent Portal and Graft Purge in Living Donor Liver Transplantation N/A
Terminated NCT01564095 - TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion Phase 2/Phase 3
Completed NCT03482544 - The Effect of Pregabalin Given Preoperatively on the Tourniquet Induced Ischemia-reperfusion Phase 4
Not yet recruiting NCT05004610 - Hypertonic Lactate After Cardiac Arrest Phase 2
Completed NCT04205253 - Tongue Depressor-related Ischemia-Reperfusion Injury in Tongue
Completed NCT03410576 - Perioperative Time Course of MMP-9 and Its Inhibitor During Carotid Artery Stenting and Carotid Endarterectomy N/A
Completed NCT03743584 - Hypothermia After Cardiac Arrest - Effects on Myocardial Function and Inflammatory Response. N/A
Recruiting NCT04005469 - Safety and Efficacy of Treprostinil (Remodulin®) In Reducing Ischemia-Reperfusion Injury During Kidney Transplantation Phase 1/Phase 2
Recruiting NCT04630535 - OSA as a Remote Ischemic Preconditioning in Vascular Surgery
Completed NCT01610401 - The Metformin-FMD Trial Phase 4
Active, not recruiting NCT00876902 - YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation Phase 2
Completed NCT03541239 - Immune Modulation by Ischemic Pre-conditioning in Healthy Individuals: Intracellular Signalling in Regulatory Cells N/A
Recruiting NCT05430620 - Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys Phase 3